STOCK TITAN

[Form 4] Innoviva, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Insider sale via tax-withholding reduced holdings. Innoviva CFO Stephen Basso reported a disposition of 237 shares of Common Stock on 08/20/2025 at a reported price of $19.95 per share. The filing states the shares were withheld by the issuer to satisfy income tax withholding obligations tied to the quarterly vesting of previously granted employee equity awards. After the transaction Mr. Basso beneficially owned 23,281 shares directly. The form is signed and dated 08/22/2025.

Vendita da insider tramite trattenuta fiscale ha ridotto le partecipazioni. Il CFO di Innoviva, Stephen Basso, ha comunicato la cessione di 237 azioni ordinarie il 20/08/2025 a un prezzo riportato di $19,95 per azione. Il modulo indica che le azioni sono state trattenute dall'emittente per soddisfare gli obblighi di ritenuta fiscale sul reddito collegati al vesting trimestrale di precedenti attribuzioni di equity ai dipendenti. Dopo la transazione il sig. Basso deteneva beneficiariamente 23.281 azioni in proprietà diretta. Il documento è firmato e datato 22/08/2025.

Venta de insider mediante retención fiscal redujo tenencias. El CFO de Innoviva, Stephen Basso, informó la enajenación de 237 acciones ordinarias el 20/08/2025 a un precio declarado de $19,95 por acción. La presentación indica que las acciones fueron retenidas por el emisor para satisfacer las obligaciones de retención de impuestos sobre la renta vinculadas al vesting trimestral de premios de acciones previamente otorgados a empleados. Tras la transacción, el Sr. Basso poseía beneficiariamente 23.281 acciones directamente. El formulario está firmado y fechado el 22/08/2025.

세금 원천징수로 인한 내부자 매각이 보유 지분을 줄였습니다. Innoviva의 CFO 스티븐 배소(Stephen Basso)는 2025-08-20에 보통주 237주를 주당 신고가 $19.95에 처분했다고 보고했습니다. 신고서에는 해당 주식이 이전에 부여된 직원 주식 보상 지급의 분기별 베스팅과 관련한 소득세 원천징수 의무를 충족하기 위해 발행사가 보류했다고 기재되어 있습니다. 거래 후 배소 씨는 직접적으로 23,281주를 실질적으로 보유하고 있었습니다. 서식에는 2025-08-22에 서명 및 기재되어 있습니다.

Vente d'initié par retenue fiscale réduisant les participations. Le directeur financier d'Innoviva, Stephen Basso, a déclaré la cession de 237 actions ordinaires le 20/08/2025 à un prix déclaré de $19,95 par action. Le dossier indique que les actions ont été retenues par l'émetteur pour satisfaire les obligations de retenue d'impôt sur le revenu liées au vesting trimestriel d'attributions d'actions antérieures aux employés. Après la transaction, M. Basso détenait directement à titre bénéficiaire 23 281 actions. Le formulaire est signé et daté du 22/08/2025.

Insider-Verkauf durch Steuerabzug verringerte Beteiligungen. Innoviva-Finanzvorstand Stephen Basso meldete die Veräußerung von 237 Aktien Stammaktien am 20.08.2025 zu einem angegebenen Kurs von $19,95 je Aktie. In der Meldung heißt es, die Aktien seien vom Emittenten einbehalten worden, um Lohnsteuerabzugspflichten im Zusammenhang mit dem quartalsweisen Vesting zuvor gewährter Mitarbeiteraktien zu erfüllen. Nach der Transaktion hielt Herr Basso unmittelbar wirtschaftlich 23.281 Aktien. Das Formular ist unterschrieben und datiert auf den 22.08.2025.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider withholding sale for taxes; not a signal of discretionary stock sale.

The Form 4 shows a small, mechanically driven disposition: 237 shares withheld at $19.95 to cover tax liabilities from vesting equity. This type of transaction typically reflects payroll withholding rather than an active sale decision by the officer. The post-transaction direct beneficial ownership of 23,281 shares remains disclosed for transparency. For investors, the event is administrative and generally not material to company valuation.

TL;DR: Compliance-focused filing documenting tax withholding on vested awards; governance processes appear followed.

The filing documents proper Section 16 reporting and manual signature, indicating adherence to reporting obligations. The explanation explicitly ties the disposition to tax withholding for vested employee awards, which is a standard corporate practice to fulfill withholding responsibilities. There is no indication of additional dispositional intent or patterned insider selling in this single-file disclosure.

Vendita da insider tramite trattenuta fiscale ha ridotto le partecipazioni. Il CFO di Innoviva, Stephen Basso, ha comunicato la cessione di 237 azioni ordinarie il 20/08/2025 a un prezzo riportato di $19,95 per azione. Il modulo indica che le azioni sono state trattenute dall'emittente per soddisfare gli obblighi di ritenuta fiscale sul reddito collegati al vesting trimestrale di precedenti attribuzioni di equity ai dipendenti. Dopo la transazione il sig. Basso deteneva beneficiariamente 23.281 azioni in proprietà diretta. Il documento è firmato e datato 22/08/2025.

Venta de insider mediante retención fiscal redujo tenencias. El CFO de Innoviva, Stephen Basso, informó la enajenación de 237 acciones ordinarias el 20/08/2025 a un precio declarado de $19,95 por acción. La presentación indica que las acciones fueron retenidas por el emisor para satisfacer las obligaciones de retención de impuestos sobre la renta vinculadas al vesting trimestral de premios de acciones previamente otorgados a empleados. Tras la transacción, el Sr. Basso poseía beneficiariamente 23.281 acciones directamente. El formulario está firmado y fechado el 22/08/2025.

세금 원천징수로 인한 내부자 매각이 보유 지분을 줄였습니다. Innoviva의 CFO 스티븐 배소(Stephen Basso)는 2025-08-20에 보통주 237주를 주당 신고가 $19.95에 처분했다고 보고했습니다. 신고서에는 해당 주식이 이전에 부여된 직원 주식 보상 지급의 분기별 베스팅과 관련한 소득세 원천징수 의무를 충족하기 위해 발행사가 보류했다고 기재되어 있습니다. 거래 후 배소 씨는 직접적으로 23,281주를 실질적으로 보유하고 있었습니다. 서식에는 2025-08-22에 서명 및 기재되어 있습니다.

Vente d'initié par retenue fiscale réduisant les participations. Le directeur financier d'Innoviva, Stephen Basso, a déclaré la cession de 237 actions ordinaires le 20/08/2025 à un prix déclaré de $19,95 par action. Le dossier indique que les actions ont été retenues par l'émetteur pour satisfaire les obligations de retenue d'impôt sur le revenu liées au vesting trimestriel d'attributions d'actions antérieures aux employés. Après la transaction, M. Basso détenait directement à titre bénéficiaire 23 281 actions. Le formulaire est signé et daté du 22/08/2025.

Insider-Verkauf durch Steuerabzug verringerte Beteiligungen. Innoviva-Finanzvorstand Stephen Basso meldete die Veräußerung von 237 Aktien Stammaktien am 20.08.2025 zu einem angegebenen Kurs von $19,95 je Aktie. In der Meldung heißt es, die Aktien seien vom Emittenten einbehalten worden, um Lohnsteuerabzugspflichten im Zusammenhang mit dem quartalsweisen Vesting zuvor gewährter Mitarbeiteraktien zu erfüllen. Nach der Transaktion hielt Herr Basso unmittelbar wirtschaftlich 23.281 Aktien. Das Formular ist unterschrieben und datiert auf den 22.08.2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Basso Stephen

(Last) (First) (Middle)
1350 OLD BAYSHORE HIGHWAY, SUITE 400

(Street)
BURLINGAME CA 94010

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Innoviva, Inc. [ INVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2025 F 237(1) D $19.95 23,281 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
/s/ Stephen Basso 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Innoviva (INVA) report on this Form 4?

The report shows a disposition of 237 shares of Common Stock on 08/20/2025 at a price of $19.95 per share.

Why were the 237 shares disposed of by Stephen Basso?

The filing states the shares were withheld by the issuer to satisfy income tax withholding obligations from quarterly vesting of employee equity grants.

How many Innoviva shares did Stephen Basso own after the transaction?

After the reported transaction Mr. Basso beneficially owned 23,281 shares directly.

What is Stephen Basso’s role at Innoviva as listed on the Form 4?

He is identified as an Officer with the title Chief Financial Officer and also checked as a Director.

When was the Form 4 signed and filed?

The signature block shows the form signed by Stephen Basso on 08/22/2025.
Innoviva

NASDAQ:INVA

INVA Rankings

INVA Latest News

INVA Latest SEC Filings

INVA Stock Data

1.26B
62.36M
0.98%
128.46%
15.38%
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGAME